These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12322721)

  • 21. Lessons learned from good manufacturing practice noncompliance.
    Peskoe MP
    Food Drug Law J; 1995; 50(1):65-70. PubMed ID: 10342986
    [No Abstract]   [Full Text] [Related]  

  • 22. Lawsuits anticipated on generic biologicals front.
    Fox JL
    Nat Biotechnol; 2003 Jul; 21(7):721-2. PubMed ID: 12833078
    [No Abstract]   [Full Text] [Related]  

  • 23. Section 8(c) of the proposed Restatement (Third) of Torts: is it really what the doctor ordered?
    Winchester JD
    Cornell Law Rev; 1997 Mar; 82(3):644-93. PubMed ID: 10343053
    [No Abstract]   [Full Text] [Related]  

  • 24. Quality control and good manufacturing practices: safety and efficacy of commercial herbals.
    Awang DV
    Food Drug Law J; 1997; 52(3):341-4. PubMed ID: 10343036
    [No Abstract]   [Full Text] [Related]  

  • 25. New POCT (point-of-care testing) guide establishes testing uniformity.
    Goldsmith BM
    MLO Med Lab Obs; 1995 Aug; 27(8):50-2. PubMed ID: 10172406
    [No Abstract]   [Full Text] [Related]  

  • 26. The "tone at the top": can it mitigate C-suite personal liability?
    Page GV; Waring MA; Kaiser GR; Cornish K
    Food Drug Law J; 2008; 63(3):723-34. PubMed ID: 19031671
    [No Abstract]   [Full Text] [Related]  

  • 27. US bill to shield drug companies from product liability.
    Lenzer J
    BMJ; 2005 Jan; 330(7482):62. PubMed ID: 15637367
    [No Abstract]   [Full Text] [Related]  

  • 28. Revisiting Factor VIII cases: is it time for an agency adjudication system?
    Su YC
    Food Drug Law J; 2008; 63(4):943-61. PubMed ID: 19601390
    [No Abstract]   [Full Text] [Related]  

  • 29. The validation life cycle.
    Agalloco J
    J Parenter Sci Technol; 1993; 47(3):142-7. PubMed ID: 8360808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total quality management: an application in a biomedical laboratory.
    Latzer DB
    Hosp Cost Manag Account; 1997 May; 9(2):1-6. PubMed ID: 10172989
    [No Abstract]   [Full Text] [Related]  

  • 32. Adequate controls for new drugs: good manufacturing practice and the 1938 federal Food, Drug, and Cosmetic Act.
    Cooper DE
    Pharm Hist; 2002; 44(1):12-23. PubMed ID: 12068915
    [No Abstract]   [Full Text] [Related]  

  • 33. Drug manufacturers' liability for injuries due to drug abuse.
    Davis WA
    Leg Med Annu; 1974; 0(0):425-43. PubMed ID: 4461874
    [No Abstract]   [Full Text] [Related]  

  • 34. CLIA '88 and purchasing for the lab: operating, labor costs add up.
    Mehl PE
    Mater Manag Health Care; 1992 Sep; 1(7):14. PubMed ID: 10171420
    [No Abstract]   [Full Text] [Related]  

  • 35. Food and Drug Administration inspection and licensing of manufacturing facilities.
    Avallone HL; Beatrice MG; Sze TT
    Bioprocess Technol; 1991; 13():315-40. PubMed ID: 1367137
    [No Abstract]   [Full Text] [Related]  

  • 36. AHP's awful losing streak.
    Whitford D
    Fortune; 1999 Nov; 140(10):52, 56. PubMed ID: 10662389
    [No Abstract]   [Full Text] [Related]  

  • 37. Con: competitive bidding cannot work in the clinical laboratory.
    Blanchard MR
    Clin Leadersh Manag Rev; 2006 Jul; 20(4):E3. PubMed ID: 16867292
    [No Abstract]   [Full Text] [Related]  

  • 38. US agency wants to limit lawsuits against drug manufacturers.
    Lenzer J
    BMJ; 2006 Jan; 332(7535):196. PubMed ID: 16439383
    [No Abstract]   [Full Text] [Related]  

  • 39. LyphoMed, FDA reach agreement.
    Wagner M
    Mod Healthc; 1988 May; 18(22):6. PubMed ID: 10287683
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluating out-of-specification laboratory results.
    Vogel PF
    J Parenter Sci Technol; 1993; 47(6):276-80. PubMed ID: 8120730
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.